Koninklijke Philips | PHG - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Danaher USD 52.95B 415M 2026-03
Demant DKK 9.84B 446M 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Fresenius EUR 19.77B 1.14B 2025-12
General Electric Aerospace USD 17.64B 417M 2026-06
Getinge SEK 30.94B 2.06B 2026-06
Globus Medical USD 4.73B 159.06M 2026-03
GN Store Nord DKK 10.12B 4.76B 2026-03
Hitachi JPY 6.57T 211.91B 2026-03
Idexx Laboratories USD 1.56B 49.28M 2026-03
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Koninklijke Philips EUR 11.42B 1.45B 2026-03
Medtronic USD 48.99B 128M 2025-12
Philips EUR 11.39B 403M 2026-03
ResMed USD 6.49B 171.03M 2026-03
Smith & Nephew USD 5.54B 331M 2025-12
Steris USD 7.18B 29.1M 2026-03
Stryker USD 22.42B 635M 2025-12
Teleflex USD 3.08B 40.33M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03